PHVS

Pharvaris N.V. PHVS

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-175.70M

Quarter to Dec 31

Free cash flow

$-137.24M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$2.23B total
FMR LLC
$227.03M+4.5%
GENERAL ATLANTIC, L.P.
$226.53M-18.4%
Foresite Capital Management IV, LLC
$165.24M0.0%
venBio Partners LLC
$160.57M+0.1%
VIKING GLOBAL INVESTORS LP
$126.33M0.0%
EQT Fund Management S.a r.l.
$118.42M0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$116.74M+8.0%
Bain Capital Life Sciences Investors, LLC
$92.52M0.0%
WELLINGTON MANAGEMENT GROUP LLP
$82.75M+12.9%
Polar Capital Holdings Plc
$80.45M+197.9%
Point72 Asset Management, L.P.
$56.75M+63.0%
Commodore Capital LP
$49.28M-25.7%
Novo Holdings A/S
$48.41M-20.0%
Saturn V Capital Management LP
$45.44M+9.4%
TCG Crossover Management, LLC
$34.86MNew
Sofinnova Ventures Inc
$30.48M+7.7%
5AM Venture Management, LLC
$27.58M0.0%
Seven Fleet Capital Management LP
$26.78M+348.4%
BlackRock, Inc.
$26.68M+1.9%
Cormorant Asset Management, LP
$25.93M-25.0%
Soleus Capital Management, L.P.
$25.27M+4.1%
Jones Hill Capital LP
$23.44M+305.9%
Patient Square Capital LP
$23.21M+36.1%
Foresite Capital Management V, LLC
$22.97M+242.1%
Kynam Capital Management, LP
$22.88M+3.3%
See all 125 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PHVS

Earnings Per Share

13fpro.ai/company/PHVS

Loading ratio trend…

PHVS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Pharvaris N.V. (PHVS): stock profile, AI score and financials

Pharvaris N.V. (PHVS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. PHVS is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), Pharvaris N.V. reports net income of $-175.7M, free cash flow of $-137.2M. Top institutional holders of PHVS by reported 13-F value include FMR, GENERAL ATLANTIC, L.P., Foresite Capital Management IV, based on the most recent SEC filings. PHVS trades on the Nasdaq exchange and files with the SEC under CIK 1830487. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PHVS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pharvaris N.V. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1830487 →